KYMO THERAPEUTICS
Kymo Therapeutics’s ambition is to move forward Metabrain Research’s proprietary program on kynurenine metabolism (KMO) inhibitors towards clinical proof of concept, before seeking partners to complete development and ensure commercialization.
KYMO THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2016-05-23
Address:
Hereford, Herefordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
Total Funding:
11 M USD
Investors List
Medicxi
Medicxi investment in Seed Round - Kymo Therapeutics